# RXRX (Recursion Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Recursion Pharmaceuticals, Inc. reported $68.23M in revenue and a net loss of $475.7M for the trailing twelve months ended September 30, 2026 (up 258.5% year over year), with a 29.2% gross margin and a -725.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/RXRX
- Markdown: https://convexityos.com/fundamentals/RXRX.md
- SEC CIK: 0001601830
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:22 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001601830&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $68.23M | +258.5% YoY |
| Operating Income | TTM | -$495.0M | -725.4% margin |
| Net Income | TTM | -$475.7M | -697.1% net margin |
| Diluted EPS | TTM | -$0.88 | Split-adjusted |
| Free Cash Flow | TTM | -$312.5M | -458.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $549.9M | Total debt: $62.89M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $74.68M | $58.84M | $44.58M | $39.84M | $10.18M | $3.96M | $2.32M |
| Cost of Revenue | $70.95M | $45.24M | $42.59M | $48.27M | $0 | $0 | -- |
| **Gross Profit** | $3.73M | $13.60M | $1.99M | -$8.43M | $10.18M | $3.96M | -- |
| Research & Development | $475.3M | $314.4M | $241.2M | $155.7M | $135.3M | $63.32M | $45.81M |
| Total Operating Expenses | -- | -- | -- | -- | $193.0M | $88.58M | $64.76M |
| **Operating Income** | -$648.1M | -$479.0M | -$350.1M | -$245.7M | -$182.8M | -$84.61M | -$62.44M |
| **EBITDA** | -$564.4M | -$442.5M | -$325.7M | -$234.0M | -$174.4M | -$80.67M | -$59.95M |
| Interest Expense | $1.81M | $1.57M | $97K | $55K | $2.95M | $1.36M | $635K |
| Income Before Tax | -$644.9M | -$464.8M | -$332.1M | -$239.5M | -$186.5M | -- | -- |
| Income Tax Expense | -$136K | -$1.13M | -$4.06M | $0 | $0 | $0 | $0 |
| **Net Income** | -$644.8M | -$463.7M | -$328.1M | -$239.5M | -$186.5M | -$87.01M | -$61.88M |
| Basic EPS | -$1.44 | -$1.69 | -$1.58 | -$1.36 | -$1.49 | -$3.99 | -$2.87 |
| **Diluted EPS** | -$1.44 | -$1.69 | -$1.58 | -$1.36 | -$1.49 | -$3.99 | -$2.87 |
| Basic Shares Outstanding | 447.4M | 274.2M | 207.9M | 175.5M | 125.3M | 21.8M | 21.6M |
| Diluted Shares Outstanding | 447.4M | 274.2M | 207.9M | 175.5M | 125.3M | 21.8M | 21.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $18.55M | $7.67M | $6.47M | $35.54M | $5.17M | $19.22M | $14.74M | $4.55M |
| Cost of Revenue | $10.04M | $11.49M | $12.49M | $14.28M | $14.69M | $20.16M | $21.83M | $12.79M |
| **Gross Profit** | $8.51M | -$3.82M | -$6.02M | $21.26M | -$9.51M | -$938K | -$7.08M | -$8.25M |
| Research & Development | $99.12M | $89.61M | $87.90M | $95.94M | $121.1M | $128.6M | $129.6M | $98.33M |
| **Operating Income** | -$123.2M | -$135.0M | -$128.5M | -$108.3M | -$172.2M | -$176.2M | -$191.4M | -$183.8M |
| **EBITDA** | -$106.6M | -$116.8M | -$108.8M | -$88.86M | -$151.2M | -$152.4M | -$172.0M | -$170.8M |
| Interest Expense | $266K | $309K | $350K | -$11K | $833K | $480K | $508K | $605K |
| Income Before Tax | -$119.0M | -$131.0M | -$122.1M | -$108.1M | -$162.2M | -$171.9M | -$202.6M | -$178.9M |
| Income Tax Expense | $25K | -$1.0K | -$4.60M | $20K | $3.0K | $0 | -$158K | $7.0K |
| **Net Income** | -$119.0M | -$131.0M | -$117.5M | -$108.1M | -$162.3M | -$171.9M | -$202.5M | -$178.9M |
| Basic EPS | -$0.22 | -$0.25 | -$0.22 | -- | -$0.36 | -$0.41 | -$0.50 | -- |
| **Diluted EPS** | -$0.22 | -$0.25 | -$0.22 | -- | -$0.36 | -$0.41 | -$0.50 | -- |
| Basic Shares Outstanding | 543.0M | 532.5M | 529.3M | -- | 447.0M | 417.4M | 402.8M | -- |
| Diluted Shares Outstanding | 543.0M | 532.5M | 529.3M | -- | 447.0M | 417.4M | 402.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $743.3M | $594.4M | $391.6M | $549.9M | $285.1M | $262.1M |
| Short-Term Investments | -- | -- | -- | $0 | $231.4M | $0 |
| **Cash & Short-Term Investments** | $743.3M | $594.4M | $391.6M | $549.9M | $516.6M | $262.1M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $34K | $156K |
| Other Current Assets | $28.57M | $38.11M | $40.25M | $15.87M | $7.51M | $2.15M |
| **Total Current Assets** | $812.8M | $714.3M | $438.1M | $569.8M | $534.7M | $266.4M |
| Property, Plant & Equipment, Net | $103.9M | $141.1M | $86.51M | $88.19M | $64.72M | $25.97M |
| Goodwill | $162.2M | $148.9M | $52.06M | $801K | $801K | $801K |
| Intangible Assets | $309.9M | $335.9M | $36.44M | $1.31M | $1.39M | $1.69M |
| Other Non-Current Assets | $12.75M | $8.82M | $261K | $0 | $35K | $650K |
| **Total Non-Current Assets** | $661.3M | $734.3M | $215.6M | $131.5M | $75.63M | $32.15M |
| **Total Assets** | $1.47B | $1.45B | $653.7M | $701.3M | $610.3M | $298.6M |
| Accounts Payable | $18.12M | $21.61M | $3.95M | $4.59M | $2.82M | $1.07M |
| Deferred Revenue (Current) | $37.60M | $61.77M | $36.43M | $56.73M | $10.00M | $10.00M |
| **Total Current Liabilities** | $147.7M | $187.5M | $93.17M | $100.3M | $46.66M | $23.10M |
| Long-Term Debt | $9.56M | $19.02M | $1.10M | -- | $723K | -- |
| Deferred Revenue (Non-Current) | $114.0M | $118.8M | $51.24M | $70.26M | $6.67M | $16.67M |
| Other Non-Current Liabilities | $2.08M | $4.73M | $0 | -- | -- | -- |
| **Total Non-Current Liabilities** | $195.6M | $226.3M | $97.09M | $115.2M | $20.75M | $33.46M |
| **Total Liabilities** | $343.3M | $413.8M | $190.3M | $215.5M | $67.41M | $56.56M |
| **Total Debt (incl. Leases)** | $68.87M | $100.1M | $50.63M | $50.37M | $723K | -- |
| Common Stock | $5.0K | $4.0K | $2.0K | $2.0K | $2.0K | $0 |
| Retained Earnings | -$2.08B | -$1.43B | -$967.6M | -$639.6M | -$400.1M | -$213.6M |
| Accumulated Other Comp. Income | $36.72M | -$7.64M | $0 | $0 | -$126K | $0 |
| **Total Stockholders' Equity** | $1.13B | $1.03B | $463.4M | $485.8M | $542.9M | -$206.3M |
| Total Equity | $1.13B | $1.03B | $463.4M | $485.8M | $542.9M | -$206.3M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $549.9M | $545.7M | $654.5M | $743.3M | $659.8M | $525.1M | $500.5M | $594.4M |
| **Cash & Short-Term Investments** | $549.9M | $545.7M | $654.5M | $743.3M | $659.8M | $525.1M | $500.5M | $594.4M |
| Other Current Assets | $22.56M | $29.32M | $24.25M | $28.57M | $29.22M | $37.34M | $32.02M | $38.11M |
| **Total Current Assets** | $616.0M | $603.5M | $709.6M | $812.8M | $714.1M | $587.2M | $584.1M | $714.3M |
| Property, Plant & Equipment, Net | $85.84M | $89.62M | $95.81M | $103.9M | $111.7M | $120.0M | $126.8M | $141.1M |
| Goodwill | $160.7M | $160.3M | $160.2M | $162.2M | $162.0M | $164.3M | $158.1M | $148.9M |
| Intangible Assets | $273.7M | $282.9M | $294.1M | $309.9M | $322.3M | $341.3M | $335.8M | $335.9M |
| Other Non-Current Assets | $12.63M | $12.19M | $12.25M | $12.75M | $14.66M | $9.42M | $14.78M | $8.82M |
| **Total Non-Current Assets** | $605.7M | $609.2M | $630.0M | $661.3M | $685.4M | $715.2M | $721.1M | $734.3M |
| **Total Assets** | $1.22B | $1.21B | $1.34B | $1.47B | $1.40B | $1.30B | $1.31B | $1.45B |
| Accounts Payable | $16.38M | $12.67M | $20.35M | $18.12M | $13.94M | $19.31M | $25.09M | $21.61M |
| Deferred Revenue (Current) | $15.81M | $27.59M | $32.79M | $37.60M | $47.36M | $39.69M | $39.65M | $61.77M |
| **Total Current Liabilities** | $122.9M | $119.9M | $129.7M | $147.7M | $155.1M | $164.0M | $142.0M | $187.5M |
| Long-Term Debt | $93K | $4.75M | $7.18M | $9.56M | $11.90M | $14.20M | $16.45M | $19.02M |
| Deferred Revenue (Non-Current) | $120.0M | $112.8M | $114.7M | $114.0M | $111.2M | $126.2M | $129.6M | $118.8M |
| Other Non-Current Liabilities | $3.96M | $2.70M | $2.02M | $2.08M | $1.03M | $1.56M | $4.79M | $4.73M |
| **Total Non-Current Liabilities** | $193.0M | $177.8M | $185.1M | $195.6M | $197.5M | $219.2M | $229.3M | $226.3M |
| **Total Liabilities** | $315.9M | $297.7M | $314.8M | $343.3M | $352.6M | $383.2M | $371.3M | $413.8M |
| **Total Debt (incl. Leases)** | $62.89M | $57.20M | $63.11M | $68.87M | $73.45M | $79.32M | $84.32M | $100.1M |
| Common Stock | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K |
| Retained Earnings | -$2.44B | -$2.32B | -$2.19B | -$2.08B | -$1.97B | -$1.81B | -$1.63B | -$1.43B |
| Accumulated Other Comp. Income | $29.63M | $27.99M | $26.66M | $36.72M | $34.09M | $43.62M | $14.14M | -$7.64M |
| **Total Stockholders' Equity** | $905.8M | $915.0M | $1.02B | $1.13B | $1.05B | $919.1M | $933.9M | $1.03B |
| Total Equity | $905.8M | $915.0M | $1.02B | $1.13B | $1.05B | $919.1M | $933.9M | $1.03B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$644.8M | -$463.7M | -$328.1M | -$239.5M | -$186.5M | -$87.01M | -$61.88M |
| Depreciation & Amortization | $83.70M | $36.49M | $24.40M | $11.76M | $8.40M | $3.94M | $2.49M |
| Stock-Based Compensation | $111.2M | $81.69M | $53.50M | $27.91M | $14.84M | $4.29M | $1.39M |
| Change in Receivables | -- | -- | -- | -- | $114K | -$5.0K | -$27K |
| Change in Payables | -$2.62M | $6.43M | -$987K | $1.77M | $1.75M | -$185K | -$340K |
| **Operating Cash Flow** | -$371.8M | -$359.2M | -$287.8M | -$83.52M | -$158.6M | -$45.40M | -$57.04M |
| Capital Expenditure | -$6.47M | -$13.70M | -$11.96M | -$37.06M | -$39.80M | -$5.83M | -$3.91M |
| **Free Cash Flow** | -$378.3M | -$372.9M | -$299.7M | -$120.6M | -$198.4M | -$51.23M | -$60.95M |
| Acquisitions, Net | $0 | $277.1M | $1.84M | $0 | $0 | -$2.60M | $0 |
| Purchases of Investments | -$3.81M | $0 | $0 | $0 | -$301.1M | $0 | $0 |
| **Investing Cash Flow** | -$16.87M | $260.1M | -$10.23M | $193.2M | -$271.7M | -$8.74M | -$3.91M |
| Common Stock Issued | $528.9M | $300.4M | $128.1M | $143.7M | $462.9M | $0 | -- |
| **Financing Cash Flow** | $521.5M | $304.1M | $140.1M | $154.3M | $458.5M | $246.1M | $120.4M |
| **Net Change in Cash** | $150.9M | $201.6M | -$157.7M | $263.8M | $28.18M | $192.0M | $59.46M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$119.0M | -$131.0M | -$117.5M | -$108.1M | -$162.3M | -$171.9M | -$202.5M | -$178.9M |
| Depreciation & Amortization | $16.54M | $18.17M | $19.67M | $19.48M | $21.04M | $23.85M | $19.33M | $12.95M |
| Stock-Based Compensation | $23.03M | $19.50M | $22.21M | $23.76M | $25.24M | $26.16M | $36.06M | $30.78M |
| Change in Payables | $3.97M | -$7.67M | $2.07M | $4.42M | -$5.89M | -$4.84M | $3.69M | $8.12M |
| **Operating Cash Flow** | -$77.41M | -$105.9M | -$81.10M | -$46.07M | -$117.4M | -$76.42M | -$132.0M | -$115.4M |
| Capital Expenditure | -$407K | -$44K | -$258K | -$1.24M | -$243K | -$3.15M | -$1.83M | -$1.30M |
| **Free Cash Flow** | -$77.81M | -$106.0M | -$81.36M | -$47.32M | -$117.6M | -$79.57M | -$133.8M | -$116.7M |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$2.31M | -$500K | -$1.00M | $0 |
| **Investing Cash Flow** | -$407K | -$1.96M | -$338K | -$1.24M | -$2.55M | -$5.81M | -$7.27M | $275.5M |
| Common Stock Issued | $85.52M | $0 | $0 | $133.4M | $254.5M | $100.0M | $41.02M | $11.03M |
| **Financing Cash Flow** | $83.14M | -$1.27M | -$3.47M | $132.0M | $251.3M | $97.66M | $40.53M | $10.64M |
| **Net Change in Cash** | $4.71M | -$108.4M | -$88.74M | $86.78M | $133.3M | $24.69M | -$93.87M | $167.2M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 5.0% | 23.1% | 4.5% | -21.2% | 100.0% | 100.0% | -- |
| **Operating Margin** | -867.9% | -814.1% | -785.3% | -616.7% | -1795.8% | -2135.7% | -2692.6% |
| **Net Profit Margin** | -863.4% | -788.0% | -736.0% | -601.0% | -1832.2% | -2196.0% | -2668.3% |
| Return on Equity (ROE) | -57.0% | -44.8% | -70.8% | -49.3% | -34.3% | -- | -- |
| Return on Assets (ROA) | -43.7% | -32.0% | -50.2% | -34.1% | -30.6% | -29.1% | -- |
| Current Ratio | 5.50x | 3.81x | 4.70x | 5.68x | 11.46x | 11.53x | -- |
| Quick Ratio | 5.03x | 3.17x | 4.20x | 5.48x | 11.07x | 11.35x | -- |
| Debt to Equity | 0.06x | 0.10x | 0.11x | 0.10x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | +26.9% | +32.0% | +11.9% | +291.5% | +156.9% | +70.8% | -- |
| Gross Profit Growth (YoY) | -72.6% | +584.2% | -- | -182.8% | +156.9% | -- | -- |
| 5Y Revenue / Share Growth | -8.2% | +99.6% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 29.2% | 3.5% | 7.2% | 5.0% | -59.0% | -3.5% | 6.5% | 23.1% |
| **Operating Margin** | -725.4% | -991.7% | -881.3% | -867.9% | -1656.2% | -1005.8% | -960.1% | -814.1% |
| **Net Profit Margin** | -697.1% | -945.9% | -842.9% | -863.4% | -1637.8% | -1004.9% | -961.3% | -788.0% |
| Return on Equity (ROE) | -52.5% | -56.7% | -54.6% | -57.0% | -68.3% | -70.6% | -61.5% | -44.8% |
| Return on Assets (ROA) | -38.9% | -42.8% | -41.8% | -43.7% | -51.1% | -49.8% | -44.0% | -32.0% |
| Current Ratio | 5.01x | 5.03x | 5.47x | 5.50x | 4.60x | 3.58x | 4.11x | 3.81x |
| Quick Ratio | 4.47x | 4.55x | 5.05x | 5.03x | 4.25x | 3.20x | 3.52x | 3.17x |
| Debt to Equity | 0.07x | 0.06x | 0.06x | 0.06x | 0.07x | 0.09x | 0.09x | 0.10x |
| **Revenue Growth (YoY)** | +258.5% | -60.1% | -56.1% | +681.7% | -80.2% | +33.3% | +6.9% | -58.3% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -167.9% | -118.0% | -369.6% | -916.6% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
